Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the full record of transactions filed by Nicholson Garry A, Director. Insider active across 1 company, notably G1 Therapeutics, Inc.. Cumulatively, 6 reports have been logged. History available since 17 June 2021. The latest transaction was filed on 13 June 2024 (Attribution). Regulator: SEC (Form 4). All data is openly available.
6 of 6 declarations
Garry A. Nicholson is a Board Member at G1 Therapeutics, Inc. He contributes to the strategic direction of the company, participating in key decisions that influence its development. His expertise in the biopharmaceutical sector is valuable to the board, enabling G1 Therapeutics to navigate effectively in a competitive environment.